by Elec23 | Jul 1, 2026 | News&events, VisMederi
First identified in Uganda in 2007, Bundibugyo ebolavirus is one of the species of the Ebola virus. Although it has historically shown a lower case fatality rate than some other Ebola virus species, typically between 25% and 40%, it remains a serious public health...
by Elec23 | Jun 19, 2026 | News&events, VisMederi
From kit design and manufacturing to biological sample management and laboratory testing, VisMederi offers a fully integrated solution for clinical trials and research programs worldwide. VisMederi, a company specialized in vaccine evaluation through advanced...
by Elec23 | Dec 3, 2025 | News&events
VisMederi is pleased to announce the establishment of VisMederi America, a new company based in Cleveland that marks a strategic milestone in the Group’s expansion into the United States. The new entity aims to strengthen VisMederi’s international presence,...
by Elec23 | Nov 27, 2025 | News&events
VisMederi is once again included in the “Leader of Growth 2026” ranking compiled by Il Sole 24 Ore in collaboration with Statista, where it ranks among the Italian companies that have performed the best in terms of revenue growth and development over the...
